AXIM Launches New Eye Care Website; Establishes Platform for Commercialization
globenewswire.com
news
2022-06-02 00:00:00

SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) ('AXIM Biotech,' 'AXIM' or 'the Company'), an international healthcare solutions company targeting ocular surface diseases, today announced the launch of its new mobile-optimized website designed to provide doctors, researchers and other medical professionals with tailored, timely information and resources that will enable them to make informed decisions when purchasing AXIM's proprietary diagnostic tests. This new AXIM Eye website features: Information about AXIM's optimized Point-of-Care FDA 501(k) cleared tests for Lactoferrin and IgE designed to accelerate the diagnosis of Dry Eye Disease and ocular allergies.
